116 related articles for article (PubMed ID: 35212274)
1. Clinical application of gelatin sponge microparticles-transcatheter arterial chemoembolization combined with synchronous antigen-presenting dendritic cell sequential reinfusion for treatment of advanced large liver cancer: A single-center, prospective, non-randomized, controlled trial.
Zhao GS; Liu S; Liu Y; Li C; Wang RY; Bian J; Zhu RP; Zhou J; Zhang YW
Medicine (Baltimore); 2022 Feb; 101(8):e28803. PubMed ID: 35212274
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study.
Kamran AU; Liu Y; Li FE; Liu S; Wu JL; Zhang YW
Medicine (Baltimore); 2015 Dec; 94(52):e2154. PubMed ID: 26717358
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study.
Zhao GS; Liu S; Liu Y; Ma J; Wang RY; Bian J; Zhou J; Wu JL; Zhang YW
World J Surg Oncol; 2021 Aug; 19(1):249. PubMed ID: 34419064
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cell-cytokine induced killer cell immunotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: safety and efficacy].
Guo W; Liu L; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):674-8. PubMed ID: 24849434
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
7. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma.
Zhou B; Yan Z; Liu R; Shi P; Qian S; Qu X; Zhu L; Zhang W; Wang J
Radiology; 2016 Aug; 280(2):630-9. PubMed ID: 26885681
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Ando Y; Kawaoka T; Amioka K; Naruto K; Ogawa Y; Yoshikawa Y; Kikukawa C; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Fukuhara T; Mori N; Takaki S; Tsuji K; Nonaka M; Hyogo H; Aisaka Y; Masaki K; Honda Y; Moriya T; Naeshiro N; Takahashi S; Imamura M; Chayama K; Aikata H
Oncology; 2021; 99(8):507-517. PubMed ID: 33946070
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
[TBL] [Abstract][Full Text] [Related]
12. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
[TBL] [Abstract][Full Text] [Related]
13. 350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy.
Zhao GS; Li C; Liu Y; Ren ZZ; Yuan XL; Zhou J; Zhang YW; Zhang M
Medicine (Baltimore); 2017 Apr; 96(16):e6629. PubMed ID: 28422858
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Arterial Chemoembolization Plus
Zhu ZX; Liao MH; Wang XX; Huang JW
Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial].
Hao MZ; Lin HL; Chen Q; Wu H; Yu WC; Chen TG
Ai Zheng; 2007 Aug; 26(8):861-5. PubMed ID: 17697548
[TBL] [Abstract][Full Text] [Related]
16. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
17. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
19. Diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery for treatment of hepatocellular carcinoma: a comparison of outcomes after N-butyl cyanoacrylate versus gelatin sponge embolization.
Noh SY; Gwon DI; Park S; Yang WJ; Chu HH; Kim JW
Acta Radiol; 2022 Jan; 63(1):48-58. PubMed ID: 33356351
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
